跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-DARUNAVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-DARUNAVIR
Authorized
STANDARD
M-DARUNAVIR
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
16e281e154ae9bc5
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
16e281e154ae9bc5
Drug Approval Canada Name
M-DARUNAVIR
Product Name
M-DARUNAVIR
Status
Cancelled Post Market
Status Date
2023-06-20
Original Market Date
2022-02-04
Din
02522284
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.08.08
Atc Original
J05AE10 DARUNAVIR
Atc Name
j 05 ae 10
Aig Number
0151656003
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
DARUNAVIR
600 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
16e281e154ae9bc5
Type
Standard
Back to Health Canada Approvals